More than two years into the COVID-19 pandemic, people are realizing that the “new normal” will probably involve learning to co-exist with SARS-CoV-2. Some treatments are available, but with new variants emerging, researchers are looking toward new strategies. In ACS Infectious Diseases, scientists now report that apratoxin S4, an anticancer drug candidate that targets a human protein, can interfere with the replication of many viruses, including SARS-CoV-2 and influenza A, offering a possible pan-viral therapy.
The University of Florida College of Pharmacy moved up two places to No. 3 in the nation for total research funding in the latest American Association of Colleges of Pharmacy, or AACP, report released June 23. The No. 3 ranking is the highest ever achieved by the college when compared to peer institutions
Three University of Florida faculty will be inducted into the Academy of Science, Engineering, and Medicine of Florida in 2022. The academy, which recognizes the work of individuals of the State of Florida who have made major achievements in science, engineering, and medicine, will present awards to the following faculty during its annual meeting on November 5-6 in Orlando.
Emerging industries require a skilled workforce to function. Sometimes, the industry begins to boom before employers can hire a sufficient number of skilled employees. That was the case for many employers in the medicinal plant industry, which includes crops like hemp, kava and kratom. Faculty from two University of Florida colleges worked together to help meet that demand with a new course.
The University of Florida College of Pharmacy and the American Pharmacists Association, or APhA, announced a new partnership today that will allow pharmacists to test patients for several non-emergency health issues.
University of Florida researchers have developed a new compound that simultaneously attacks two key proteins critical for a cancer cell’s survival, a discovery that could aid in the development of more effective leukemia, lung and colon cancer drugs.
Julie Johnson, Pharm.D., dean and distinguished professor in the University of Florida College of Pharmacy, was presented the 2021 Precision Medicine World Conference, or PMWC, Luminary Award on Sept. 23, 2021 in Pittsburgh.
University of Florida researchers are developing a new artificial intelligence tool that will help clinicians identify patients at high risk for opioid use disorder and overdose.
UF medicinal chemists report promising results from a study focused on new ways to of treating several types of antibiotic-resistant bacteria, advances that may help in the battle against MRSA, tuberculosis and other infectious pathogens.
An anticancer drug developed by researchers from the University of Florida College of Pharmacy has become the first drug of its kind allowed to proceed to clinical trial by the U.S. Food and Drug Administration.